Discovery of Novel, Potent, Brain-Permeable, and Orally Efficacious Positive Allosteric Modulator of α7 Nicotinic Acetylcholine Receptor [4-(5-(4-Chlorophenyl)-4-methyl-2-propionylthiophen-3-yl)benzenesulfonamide]: Structure-Activity Relationship and Preclinical Characterization

被引：19

作者：

Sinha, Neelima ^{[1
]}

Karche, Navnath P. ^{[1
]}

Verma, Mahip Kalyan ^{[1
]}

Walunj, Sameer S. ^{[1
]}

Nigade, Prashant B. ^{[1
]}

Jana, Gourhari ^{[1
]}

Kurhade, Sanjay P. ^{[1
]}

Hajare, Anil K. ^{[1
]}

Tilekar, Ajay R. ^{[1
]}

Jadhav, Ganesh R. ^{[1
]}

Thube, Baban R. ^{[1
]}

Shaikh, Javed S. ^{[1
]}

Balgude, Sudhakar ^{[1
]}

Singh, Lairikyengbam Bikramjit ^{[1
]}

Mahimane, Vijaya ^{[1
]}

Adurkar, Shridhar K. ^{[1
]}

Hatnapure, Girish ^{[1
]}

Raje, Firoj ^{[1
]}

Bhosale, Yogesh ^{[1
]}

Bhanage, Dnyaneshwar ^{[1
]}

Sachchidanand, Sachchidanand ^{[1
]}

Dixit, Ruchi ^{[1
]}

Gupta, Rajesh ^{[1
]}

Bokare, Anand M. ^{[1
]}

Dandekar, Manoj ^{[1
]}

Bharne, Ashish ^{[1
]}

Chatterjee, Manavi ^{[1
]}

Desai, Sagar ^{[1
]}

Koul, Sarita ^{[1
]}

Modi, Dipak ^{[1
]}

Mehta, Maneesh ^{[1
]}

Patil, Vinod ^{[1
]}

Singh, Minakshi ^{[1
]}

Gundu, Jayasagar ^{[1
]}

Goel, Rajan N. ^{[1
]}

Shah, Chirag ^{[1
]}

Sharma, Sharad ^{[1
]}

Bakhle, Dhananjay ^{[1
]}

Kamboj, Rajender Kumar ^{[1
]}

Palle, Venkata P. ^{[1
]}

机构：

[1] Lupin Ltd, Lupin Res Pk, Novel Drug Discovery & Dev, Survey 46 A-47 A, Pune 412115, Maharashtra, India

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2020年 / 63卷 / 03期

关键词：

COGNITIVE IMPAIRMENT; PARTIAL AGONIST; SCHIZOPHRENIA; TRANSMISSION; SELECTIVITY; ACTIVATION; EVP-6124; RODENTS; SAFETY; MEMORY;

D O I：

10.1021/acs.jmedchem.9b01569

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The discovery of a series of thiophenephenyl-sulfonamides as positive allosteric modulators (PAM) of alpha 7 nicotinic acetylcholine receptor (alpha 7 nAChR) is described. Optimization of this series led to identification of compound 28, a novel PAM of alpha 7 nicotinic acetylcholine receptor (alpha 7 nAChR). Compound 28 showed good in vitro potency, with pharmacokinetic profile across species with excellent brain penetration and residence time. Compound 28 robustly reversed the cognitive deficits in episodic/working memory in both time-delay and scopolamine-induced amnesia paradigms in the novel object and social recognition tasks, at very low dose levels. Additionally, compound 28 has shown excellent safety profile in phase 1 clinical trials and is being evaluated for efficacy and safety as monotherapy in patients with mild to moderate Alzheimer's disease.

引用

页码：944 / 960

页数：17

共 45 条

[1] Discovery of 4-(5-(4-Chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744) as a Novel Positive Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor
Faghih, Ramin
Gopalakrishnan, Sujatha M.
Gronlien, Jens Halvard
Malysz, John
Briggs, Clark A.
Wetterstrand, Caroline
Ween, Hilde
Curtis, Michael P.
Sarris, Kathy A.
Gfesser, Gregory A.
El-Kouhen, Rachid
Robb, Holly M.
Radek, Richard J.
Marsh, Kennan C.
Bunnelle, William H.
Gopalakrishnan, Murali
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (10) : 3377 - 3384
[2] In Vitro Pharmacological Characterization of a Novel Allosteric Modulator of α7 Neuronal Acetylcholine Receptor, 4-(5-(4-Chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744), Exhibiting Unique Pharmacological Profile
Malysz, John
Gronlien, Jens Halvard
Anderson, David J.
Hakerud, Monika
Thorin-Hagene, Kirsten
Ween, Hilde
Wetterstrand, Caroline
Briggs, Clark A.
Faghih, Ramin
Bunnelle, William H.
Gopalakrishnan, Murali
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 330 (01): : 257 - 267
[3] Discovery and Preclinical Characterization of 3-((4-(4-Chlorophenyl)-7-fluoroquinoline-3-yl)sulfonyl)benzonitrile, a Novel Non-acetylenic Metabotropic Glutamate Receptor 5 (mGluR5) Negative Allosteric Modulator for Psychiatric Indications
Galambos, Janos
Bielik, Attila
Krasavin, Mikhail
Orgovan, Zoltan
Domany, Gyorgy
Nogradi, Katalin
Wagner, Gabor
Balogh, Gyorgy T.
Beni, Zoltan
Koti, Janos
Szakacs, Zoltan
Bobok, Amrita
Kolok, Sandor
Miko-Bakk, Monika L.
Vastag, Monika
Saghy, Katalin
Laszy, Judit
Halasz, Attila Sandor
Balazs, Ottilia
Gal, Krisztina
Greiner, Istvan
Szombathelyi, Zsolt
Keseru, Gyorgy M.
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (06) : 2470 - 2484
[4] Characterization of 2-[[4-Fluoro-3-(trifluoromethyl)phenyl]amino]-4-(4-pyridinyl)-5-thiazolemethanol (JNJ-1930942), a Novel Positive Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor
Dinklo, Theo
Shaban, Hamdy
Thuring, Jan Willem
Lavreysen, Hilde
Stevens, Karen E.
Zheng, Lijun
Mackie, Claire
Grantham, Christopher
Vandenberk, Ine
Meulders, Greet
Peeters, Luc
Verachtert, Hanne
De Prins, Erik
Lesage, Anne S. J.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 336 (02): : 560 - 574
[5] Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789)
Zanaletti, Riccardo
Bettinetti, Laura
Castaldo, Cristiana
Cocconcelli, Giuseppe
Comery, Thomas
Dunlop, John
Gaviraghi, Giovanni
Ghiron, Chiara
Haydar, Simon N.
Jow, Flora
Maccari, Laura
Micco, Iolanda
Nencini, Arianna
Scali, Carla
Turlizzi, Elisa
Valacchit, Michela
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (10) : 4806 - 4823
[6] Discovery of (1R,2R)-N-(4-(6-isopropylpyridin-2-yl)-3-(2-methyl-2H-indazol-5-yl)isothiazol-5-yl)-2-methylcyclopropanecarboxamide, a potent and orally efficacious mGlu5 receptor negative allosteric modulator
Hao, Junliang
Dehlinger, Veronique
Fivush, Adam M.
Rudyk, Helene C. E.
Britton, Thomas C.
Hollinshead, Sean P.
Vokits, Benjamin P.
Clark, Barry P.
Henry, Steven S.
Massey, Steven M.
Peng, Langu
Dressman, Bruce A.
Heinz, Beverly A.
Roberts, Edda F.
Bracey-Walker, Mallorie R.
Swanson, Steven
Catlow, John T.
Love, Patrick L.
Tepool, Anita D.
Peters, Steven C.
Simmons, Rosa Maria A.
Iyengar, Smriti
McKinzie, David L.
Monn, James A.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (05) : 1249 - 1252
[7] Preliminary structure-activity relationship studies on some novel s-substituted aliphatic analogues of 5-{1-[(4-chlorophenyl) sulfonyl]-3-piperidinyl}-1, 3, 4-oxadiazol-2-yl sulfide
Nafeesa, Khadija
Aziz-ur-Rehman
Abbasi, M. Athar
Khan, Khalid M.
Ahmed, Irshad
Hassan, Sidra
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2016, 15 (07) : 1507 - 1514
[8] In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE)
Perdona, Elisabetta
Costantini, Vivian J. A.
Tessari, Michela
Martinelli, Prisca
Carignani, Corrado
Valerio, Enzo
Mok, M. H. Selina
Zonzini, Laura
Visentini, Filippo
Gianotti, Massimo
Gordon, Laurie
Rocheville, Magalie
Corsi, Mauro
Capelli, Anna Maria
NEUROPHARMACOLOGY, 2011, 61 (5-6) : 957 - 966
[9] Discovery of 2-(4-((1H-1,2,4-triazol-1-yl)methyl)-5-(4-bromophenyl)-1-(2-chlorophenyl)-1H-pyrazol-3-yl)-5-tert-butyl-1,3,4-thiadiazole (GCC2680) as a potent, selective and orally efficacious cannabinoid-1 receptor antagonist
Lee, Jinhwa
Seo, Hee Jeong
Lee, Suk Ho
Kim, Jeongmin
Jung, Myung Eun
Lee, Sung-Han
Song, Kwang-Seop
Lee, Junwon
Kang, Suk Youn
Kim, Min Ju
Kim, Mi-Soon
Son, Eun-Jung
Lee, MinWoo
Han, Ho-Kyun
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (17) : 6377 - 6388
[10] Discovery, Synthesis, and Structure-Activity Relationship Development of a Series of N-4-(2,5-Dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): Characterization of a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4) with Oral Efficacy in an Antiparkinsonian Animal Model
Jones, Carrie K.
Engers, Darren W.
Thompson, Analisa D.
Field, Julie R.
Blobaum, Anna L.
Lindsley, Stacey R.
Zhou, Ya
Gogliotti, Rocco D.
Jadhav, Satyawan
Zamorano, Rocio
Bogenpohl, Jim
Smith, Yoland
Morrison, Ryan
Daniels, J. Scott
Weaver, C. David
Conn, P. Jeffrey
Lindsley, Craig W.
Niswender, Colleen M.
Hopkins, Corey R.
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (21) : 7639 - 7647

← 1 2 3 4 5 →